| 66-22-8 |
| 2,4(1H,3H)-Pyrimidinedione |
| pyrimidine-2,4(1H,3H)-dione |
| Pyrod |
| 2,4-Dioxopyrimidine |
| Hybar X |
| 2,4-Pyrimidinedione |
| Pirod |
| 1H-Pyrimidine-2,4-dione |
| 1,2,3,4-tetrahydropyrimidine-2,4-dione |
| CHEBI:17568 |
| NSC-3970 |
| DTXSID4021424 |
| SQ-6201 |
| SQ-7726 |
| SQ-8493 |
| BMS-205603-01 |
| 56HH86ZVCT |
| NSC3970 |
| DTXCID101424 |
| 2, 4-Dioxopyrimidine |
| RefChem:6338 |
| 2-hydroxy-4-(1H)-pyrimidione |
| 2-hydroxy-4-(3H)-pyrimidione |
| 4-hydroxy-2-(1H)-pyrimidione |
| 200-621-9 |
| 2,4-Dihydroxypyrimidine |
| pyrimidine-2,4-diol |
| 2,4-Pyrimidinediol |
| 51953-14-1 |
| Uracil [USAN] |
| MFCD00006016 |
| RU 12709 |
| Ura |
| 2,4-Pyrimidinediol (9CI) |
| CCRIS 3077 |
| Uracyl |
| Urazil |
| 2-Hydroxy-4(3H)-pyrimidinone |
| SQ 6201 |
| SQ 7726 |
| SQ 8493 |
| BMS 205603-01 |
| AI3-25470 |
| NSC 3970 |
| Lamivudine impurity e |
| 2-Hydroxy-4(1H)-pyrimidinone |
| 66255-05-8 |
| Lamivudine impurity e rs |
| 144104-68-7 |
| 4-Hydroxy-2(1H)-pyrimidinone |
| Fluorouracil specified compound c |
| NCGC00181030-01 |
| 4-Hydroxyuracil |
| CAS-66-22-8 |
| CID 5274267 |
| Pyrimidine-2,4(1H,3H)-dione (Uracil) |
| Uracil (8CI) |
| Uracil [USAN:JAN] |
| 2(1H)-Pyrimidinone, 4-hydroxy- |
| 2(1H)-Pyrimidinone, 6-hydroxy- |
| 4(3H)-Pyrimidinone, 2-hydroxy- |
| EINECS 200-621-9 |
| UNII-56HH86ZVCT |
| 66224-60-0 |
| 8h-uracil |
| hydroxypyrimidinone |
| Uracil (Standard) |
| 2,6-Dioxypyrimidin |
| 2,4-Dioxypyrimidine |
| 2,4(1H,3H)-Pyrimidinedione (9CI) |
| pyrimidine-2,4-dione |
| Fluorouracil Impurity C |
| Uracil, 99% |
| 1ui0 |
| Uracil (JAN/USAN) |
| 2,3H)-Pyrimidinedione |
| 2,6-Dihydroxypyrimidine |
| URACIL [JAN] |
| URACIL [USP-RS] |
| URACIL [WHO-DD] |
| Lamivudine EP Impurity F |
| URACIL [MI] |
| URACIL [MART.] |
| bmse000187 |
| bmse000940 |
| CHEMBL566 |
| Epitope ID:120356 |
| NCIMech_000782 |
| SCHEMBL8235 |
| Uracil, >=99.0% |
| pyrimidine, 2,4-dihydroxy- |
| SCHEMBL29730 |
| SCHEMBL80962 |
| SCHEMBL94310 |
| 51953-19-6 |
| MLS001304993 |
| SCHEMBL144010 |
| SCHEMBL151239 |
| SCHEMBL537174 |
| SCHEMBL877869 |
| SCHEMBL925137 |
| GTPL4560 |
| orb1310972 |
| SCHEMBL1050479 |
| SCHEMBL5089507 |
| SCHEMBL6286831 |
| SCHEMBL6434097 |
| SCHEMBL6434098 |
| SCHEMBL7267501 |
| SCHEMBL7335265 |
| SCHEMBL9734266 |
| SCHEMBL9779787 |
| 2,4-(1h,3h)-pyrimidinedione |
| SCHEMBL10580164 |
| SCHEMBL11607890 |
| SCHEMBL13276278 |
| SCHEMBL29525634 |
| SCHEMBL31434533 |
| HY-I0960R |
| Uracil, >=99.0% (T) |
| 1,3-dihydropyrimidine-2,4-dione |
| DTXSID501007260 |
| HMS2234E19 |
| HMS3264C13 |
| HMS3373E18 |
| HMS3652N05 |
| HMS5082D06 |
| Pharmakon1600-01502345 |
| (4-Hydroxypyrimidin-2-yl)oxidanyl |
| 4(1H)-Pyrimidinone, 2-hydroxy- |
| BCP26546 |
| HY-I0960 |
| NSC29742 |
| ZAA89752 |
| Tox21_112680 |
| Tox21_201023 |
| BDBM50549809 |
| CCG-35866 |
| MSK000882 |
| NSC-29742 |
| NSC759649 |
| s4177 |
| SBB058492 |
| STK301734 |
| STL124066 |
| AKOS000119989 |
| AKOS002303991 |
| Tox21_112680_1 |
| 4(3H)-Pyrimidinone,2-hydroxy-(9ci) |
| CCG-213042 |
| CS-W020104 |
| DB03419 |
| FU01843 |
| NSC-759649 |
| PS-5279 |
| SB55489 |
| SB55884 |
| NCGC00181030-02 |
| NCGC00247663-01 |
| NCGC00258576-01 |
| Uracil, Vetec(TM) reagent grade, 98% |
| NCI60_003718 |
| SMR000752912 |
| SY008943 |
| DB-030518 |
| DB-103964 |
| DB-268940 |
| DB-268966 |
| DB-272084 |
| DB-272202 |
| LAMIVUDINE IMPURITY F [EP IMPURITY] |
| FLUOROURACIL IMPURITY C [EP IMPURITY] |
| LAMIVUDINE IMPURITY E [USP IMPURITY] |
| NS00002070 |
| ST45061548 |
| SW220239-1 |
| U0013 |
| EN300-17138 |
| Uracil, suitable for cell culture, BioReagent |
| C00106 |
| D00027 |
| SBI-0053640.0002 |
| AB00171810_03 |
| AB00171810_04 |
| AB00918623-05 |
| AC-907/30002021 |
| F036407 |
| Q182990 |
| BRD-K80129304-001-08-1 |
| BRD-K80129304-001-09-9 |
| Z56889474 |
| F1796-0008 |
| FLUOROURACIL SPECIFIED COMPOUND C [USP IMPURITY] |
| E2FC11E5-1887-46DF-B415-82313CE9B2BD |
| Uracil, United States Pharmacopeia (USP) Reference Standard |
| 2,4(1H,3H)-Pyrimidinedione;2,4-Dihydroxypyrimidine;2,4-Pyrimidinediol |
| Fluorouracil impurity C, European Pharmacopoeia (EP) Reference Standard |
| InChI=1/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8 |
| Uracil, Pharmaceutical Secondary Standard; Certified Reference Material |
|
There are more than 10 synonyms. If you wish to see them all click here.
|